2021
DOI: 10.1016/j.clml.2020.08.024
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of Single Low-Dose Rasburicase in Management of Tumor Lysis Syndrome in Leukemia and Lymphoma Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…2 Rasburicase was spiked at a lower concentration than the product characteristics document 2 and NICE 1 recommended 200 μg/kg due to widespread use of a lower dose of rasburicase including at our centre. 11,12 After thorough mixing, serum was pipetted in one tube each of plain (no additive, Greiner item 454001) and tripotassium-EDTA (Greiner item 454086), and two FC Mix tubes (Greiner item 454510) to the recommended volume and mixed by inversions as per Greiner tube recommendation. Additionally, a pre-chilled (ice-water) lithium heparin tube was spiked with the same concentration of rasburicase.…”
Section: Methodsmentioning
confidence: 99%
“…2 Rasburicase was spiked at a lower concentration than the product characteristics document 2 and NICE 1 recommended 200 μg/kg due to widespread use of a lower dose of rasburicase including at our centre. 11,12 After thorough mixing, serum was pipetted in one tube each of plain (no additive, Greiner item 454001) and tripotassium-EDTA (Greiner item 454086), and two FC Mix tubes (Greiner item 454510) to the recommended volume and mixed by inversions as per Greiner tube recommendation. Additionally, a pre-chilled (ice-water) lithium heparin tube was spiked with the same concentration of rasburicase.…”
Section: Methodsmentioning
confidence: 99%
“…Previously conducted clinical trials have demonstrated the superiority of rasburicase compared to allopurinol in producing a steep and rapid decrease in plasma uric acid concentrations in pediatric patients with TLS [ 18 20 ]. A single low-dose of rasburicase has shown effectiveness in pediatric patients with NHL and AL in the management of TLS, with significant cost reductions [ 21 , 22 ]. Rasburicase was also efficient in the prevention and management of TLS in resource-limited settings [ 22 , 23 ].…”
Section: Introductionmentioning
confidence: 99%
“…A single low-dose of rasburicase has shown effectiveness in pediatric patients with NHL and AL in the management of TLS, with significant cost reductions [ 21 , 22 ]. Rasburicase was also efficient in the prevention and management of TLS in resource-limited settings [ 22 , 23 ].…”
Section: Introductionmentioning
confidence: 99%